Belgium faces the 4th covid wave. You and I are all asked to stand together in the fight against the Corona virus. We wish to inform you on the new protective measures we implemented for the upcoming 46th BSRM Scientific Meeting. The 46th Scientific Meeting will take place in person but with some changes (see… Continue reading 46th Meeting: Welcome, praticalities, COVID-19 measures
Read the BSRM Position statement about "COVID-19 Vaccination and Fertility" here. Please find an overview of all BSRM Position Statements and other links here: https://bsrm.be/covid-19-and-art/
You are invited to support a unique opportunity for clinical embryologists/IVF laboratory professionals. A collaboration between the Reproductive Biology Laboratory (Department of Obstretrics & Gynaecology at the university of Pretoria-south-Africe), Life In Vitro Academy (UK), and the Middle East Fertility Society Embryology Specialty Interest Group seeks to take the pulse of the world’s embryologists’ workforce.… Continue reading International Embryology Survey
Met de steun van Pink Ribbon lanceert Family Hope haar vernieuwd informatieplatform over vruchtbaarheid tijdens en na borstkankerhttp://family-hope.eu/nl/startpagina/ Family Hope lance sa nouvelle plateforme d’information sur la fertilité pendant et après un cancer du sein, avec le soutien de l’asbl Pink Ribbonhttp://family-hope.eu/fr/accueil/
SAVE THE DATE46th Scientific meeting26-27 November 2021Dolce la Hulpe CALL FOR ABSTRACTSClinicians and scientists can present their work on any aspect of Human Reproduction.► Deadline: 1 October 2021► Guidelines:– Title, authors, affiliations and corresponding email– Abstract (max. 400 words): preferred structure: objective(s), design and methods, results, conclusions– Please indicate the category: “basic research” or “clinical”–… Continue reading Abstract submission for the 46th BSRM Scientific Meeting is open
Dear colleagues, The last BSRM statement has been revised according to the recent recommendation of CSS/HGR 22/04/2021 regarding the vaccination of pregnant and breastfeeding women. Read the "BSRM Position statement about the COVID-19 vaccination strategy" here. Please find an overview of all BSRM Position Statements and other links here: https://bsrm.be/covid-19-and-art/
WHO recognizes that the provision of high-quality services for family-planning, including fertility care services, is one of the core elements of reproductive health. Availability, access, and quality of interventions to address infertility remain a challenge in most countries. Read the WHO fact sheet here: https://www.who.int/news-room/fact-sheets/detail/infertility Read the editorial “WHO fact sheet on infertility gives hope to… Continue reading WHO Factsheet & Editorial by Willem Ombelet
Over the past ten years many new tests and techniques were validated and made available for clinical and research purposes. Prompted by these considerations, WHO established an Editorial Board (EB) to review all the methods described in the 5th Edition of the Manual, with a view to endorsing, changing, or updating them. From 16 March… Continue reading WHO Invites Public Review of Latest Version of Laboratory Manual for the Examination and Processing of Human Semen
Dear colleagues, The last BSRM position statement has to be revised according to the recent actualization of the CSS-HGR position (n°9622, available on www.css-hgr.be or BSRM website). Read the "Revised BSRM Position statement about the COVID-19 vaccination strategy" here.
The time for COVID-19 vaccination has started! At present, two vaccines have been approved in EU and are available in Belgium (Pfizer-BioNtech BNT162b2 and Moderna mRNA-1273), both based on mRNA technologies. The CSS has defined the vaccination strategy in July 2020 (N°9597&9611) and has recently published special recommendation regarding pregnant women (December 2020 N°9622). Documents… Continue reading New BSRM position statement – COVID-19 vaccination strategy
BSRM 